Orlando—Novel targeted compounds used alone or in combination with current therapies to treat leukemias and lymphomas have generated positive results in studies highlighted at the recent annual meeting of the American Society of Hematology.
Over the years, researchers and clinicians have come to understand the biochemical aspects of hematology better than most disciplines of medicine.
Hampton T. New Blood Cancer Therapies Under Study. JAMA. 2007;297(5):457-458. doi:10.1001/jama.297.5.457